StockData
CNBX Pharmaceuticals Inc. logo

CNBX Pharmaceuticals Inc. (CNBX) stock

CNBXOTCPharmaceutical PreparationsFiscal year ends August 31
Financials through Q3 FY2026, quarter ended May 31, 2026Last filing: 10-Q on Jun 24, 2026Score 0/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $197.79KP/E –Yield –

CNBX Pharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

CNBX Pharmaceuticals's total debt was $120.00K at May 31, 2026. For fiscal 2025 it was $0.

Annual total debt

PeriodPeriod endValueChange
FY2025Aug 31, 2025$0–

Quarterly total debt

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026May 31, 2026$120.00K–
Q2 FY2026CQ1 2026Feb 28, 2026$75.00K–
Q4 FY2025CQ3 2025Aug 31, 2025$0–

More CNBX Pharmaceuticals figures

See a number that looks wrong?